搜索
广告图
All categories
/
/
/
Optipharm: using the technology of different islets of Langerhans to seize the market of biological agents for diabetes treatment in China

Optipharm: using the technology of different islets of Langerhans to seize the market of biological agents for diabetes treatment in China

(Summary description)SouthKoreanlifesciencefirmoptipharmwillusexenoislettechnologytoenterthe27trillionwonChinesediabetestreatmentmarket,accordingtoSouthKoreanportalnaver.SouthKoreanlifesciencefirmoptipharmwillusexenoislettechnologytoenterthe27trillionwonChinesediabetestreatmentmarket,accordingtoSouthKoreanportalnaver.SouthKoreanlifesciencefirmoptipharmwillusexenoislettechnologytoenterthe27trillionwonChinesediabetestreatmentmarket,accordingtoSouthKoreanportalnaver.SouthKoreanlifesciencefirmoptipharmwillusexenoislettechnologytoenterthe27trillionwonChinesediabetestreatmentmarket,accordingtoSouthKoreanportalnaver.SouthKoreanlifesciencefirmoptipharmwillusexenoislettechnologytoenterthe27trillionwonChinesediabetestreatmentmarket,accordingtoSouthKoreanportalnaver.SouthKoreanlifesciencefirmoptipharmwillusexenoislettechnologytoenterthe27trillionwonChinesediabetestreatmentmarket,accordingtoSouthKoreanportalnaver.SouthKoreanlifesciencefirmoptipharmwillusexenoislettechnologytoenterthe27trillionwonChinesediabetestreatmentmarket,accordingtoSouthKoreanportalnaver.SouthKoreanlifesciencefirmoptipharmwillusexenoislettechnologytoenterthe27trillionwonChinesediabetestreatmentmarket,accordingtoSouthKoreanportalnaver.